US Stock MarketDetailed Quotes

CRBU Caribou Biosciences

Watchlist
  • 1.850
  • -0.090-4.64%
Close Aug 12 16:00 ET
  • 1.850
  • 0.0000.00%
Post 16:39 ET
167.17MMarket Cap-1401P/E (TTM)

Caribou Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-116.44%-32.87M
-33.16%-37.2M
-2.56%-93.29M
14.63%-21.38M
-28.66%-28.79M
30.58%-15.19M
-28.91%-27.94M
-179.73%-90.97M
-17.09%-25.04M
-49.50%-22.38M
Net income from continuing operations
-27.70%-37.7M
-47.03%-41.23M
-2.66%-102.07M
-27.85%-34.51M
62.46%-10M
-10.57%-29.52M
-46.92%-28.04M
-48.56%-99.42M
-46.05%-26.99M
-27.05%-26.65M
Operating gains losses
----
----
---34K
--0
--0
--0
---34K
----
----
----
Depreciation and amortization
38.74%856K
20.54%710K
117.32%3.53M
46.25%740K
250.89%1.58M
72.35%617K
91.23%589K
64.84%1.62M
85.35%506K
73.08%450K
Other non cash items
-1,744.97%-2.78M
561.92%1.72M
21,933.33%3.28M
415.48%2.18M
-70.12%666K
151.37%169K
121.24%260K
-100.62%-15K
67.98%-691K
-7.24%2.23M
Change In working capital
-76.33%2.86M
64.06%-849K
-74.07%-7.32M
4,025.00%5.02M
-3,021.50%-22.07M
595.17%12.09M
53.76%-2.36M
-114.46%-4.2M
95.18%-128K
-129.35%-707K
-Change in receivables
-36.64%697K
236.87%245K
-76.73%805K
284.94%1.28M
-294.42%-1.39M
238.46%1.1M
-108.58%-179K
216.77%3.46M
198.52%332K
15.27%717K
-Change in prepaid assets
9.36%596K
-141.86%-758K
281.13%1.77M
43.26%914K
-18.80%-1.5M
-42.57%545K
239.74%1.81M
75.88%-975K
149.69%638K
-38.06%-1.27M
-Change in payables and accrued expense
-38.80%2.6M
119.58%516K
1,084.64%7.56M
306.85%3.63M
197.82%2.33M
84.17%4.25M
44.46%-2.64M
-114.17%-768K
414.84%891K
-78.68%781K
-Change in other current assets
178.95%159K
-437.10%-209K
91.49%-48K
91.13%-18K
-325.71%-149K
-64.60%57K
112.73%62K
-78.48%-564K
-23.03%-203K
---35K
-Change in other current liabilities
-96.28%-369K
115.79%51K
-52.39%-637K
-179.03%-346K
326.80%220K
-80.77%-188K
-247.31%-323K
-158.02%-418K
11.43%-124K
-1,112.50%-97K
-Change in other working capital
-112.97%-821K
36.74%-694K
-239.46%-16.77M
74.19%-429K
-2,572.61%-21.57M
433.40%6.33M
-91.78%-1.1M
-115.87%-4.94M
-271.81%-1.66M
15.14%-807K
Cash from discontinued investing activities
Operating cash flow
-116.44%-32.87M
-33.16%-37.2M
-2.56%-93.29M
14.63%-21.38M
-28.66%-28.79M
30.58%-15.19M
-28.91%-27.94M
-179.73%-90.97M
-17.09%-25.04M
-49.50%-22.38M
Investing cash flow
Cash flow from continuing investing activities
91.61%21.2M
10.88%22.96M
26.88%-68.18M
-2,790.09%-31.47M
-721.15%-68.48M
179.18%11.06M
128.71%20.7M
47.14%-93.25M
100.67%1.17M
-332.07%-8.34M
Net PPE purchase and sale
12.22%-2.24M
28.71%-1.45M
-79.93%-11.61M
-29.60%-2.28M
-250.96%-4.75M
2.56%-2.55M
-180.91%-2.03M
-204.29%-6.45M
-156.50%-1.76M
-45.59%-1.35M
Net intangibles purchase and sale
---125K
---1.5M
--0
--0
--0
--0
--0
40.00%-600K
---300K
----
Net investment purchase and sale
73.06%23.57M
13.94%25.9M
34.37%-56.57M
-1,004.77%-29.2M
-853.24%-63.72M
219.94%13.62M
131.85%22.73M
50.26%-86.2M
101.86%3.23M
---6.69M
Cash from discontinued investing activities
Investing cash flow
91.61%21.2M
10.88%22.96M
26.88%-68.18M
-2,790.09%-31.47M
-721.15%-68.48M
179.18%11.06M
128.71%20.7M
47.14%-93.25M
100.67%1.17M
-332.07%-8.34M
Financing cash flow
Cash flow from continuing financing activities
-99.25%132K
660.35%12.49M
7,133.85%154.3M
-133.86%-43K
20,561.77%135.13M
4,753.87%17.57M
65.86%1.64M
-99.51%2.13M
-72.39%127K
-99.80%654K
Net common stock issuance
-96.14%669K
908.82%11.33M
--152.72M
---113K
--134.38M
--17.34M
--1.12M
--0
--0
--0
Proceeds from stock option exercised by employees
-327.54%-537K
122.74%1.16M
-26.02%1.58M
-44.88%70K
15.14%753K
-34.81%236K
-47.58%519K
-16.39%2.13M
-72.39%127K
-31.95%654K
Cash from discontinued financing activities
Financing cash flow
-99.25%132K
660.35%12.49M
7,133.85%154.3M
-133.86%-43K
20,561.77%135.13M
4,753.87%17.57M
65.86%1.64M
-99.51%2.13M
-72.39%127K
-99.80%654K
Net cash flow
Beginning cash position
-6.33%49.45M
-12.29%51.21M
-75.72%58.38M
26.75%104.1M
-40.96%66.24M
-64.25%52.79M
-75.72%58.38M
1,407.34%240.47M
-81.13%82.13M
-13.41%112.19M
Current changes in cash
-185.75%-11.53M
68.50%-1.76M
96.06%-7.18M
-122.75%-52.9M
225.96%37.86M
137.90%13.45M
93.97%-5.59M
-181.10%-182.08M
87.82%-23.75M
-109.83%-30.06M
End cash Position
-42.77%37.91M
-6.33%49.45M
-12.29%51.21M
-12.29%51.21M
26.75%104.1M
-40.96%66.24M
-64.25%52.79M
-75.72%58.38M
-75.72%58.38M
-81.13%82.13M
Free cash flow
-98.62%-35.23M
-33.97%-40.15M
-7.02%-104.9M
12.71%-23.66M
-39.58%-33.54M
27.58%-17.74M
-33.82%-29.97M
-175.03%-98.02M
-22.77%-27.1M
-42.21%-24.03M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -116.44%-32.87M-33.16%-37.2M-2.56%-93.29M14.63%-21.38M-28.66%-28.79M30.58%-15.19M-28.91%-27.94M-179.73%-90.97M-17.09%-25.04M-49.50%-22.38M
Net income from continuing operations -27.70%-37.7M-47.03%-41.23M-2.66%-102.07M-27.85%-34.51M62.46%-10M-10.57%-29.52M-46.92%-28.04M-48.56%-99.42M-46.05%-26.99M-27.05%-26.65M
Operating gains losses -----------34K--0--0--0---34K------------
Depreciation and amortization 38.74%856K20.54%710K117.32%3.53M46.25%740K250.89%1.58M72.35%617K91.23%589K64.84%1.62M85.35%506K73.08%450K
Other non cash items -1,744.97%-2.78M561.92%1.72M21,933.33%3.28M415.48%2.18M-70.12%666K151.37%169K121.24%260K-100.62%-15K67.98%-691K-7.24%2.23M
Change In working capital -76.33%2.86M64.06%-849K-74.07%-7.32M4,025.00%5.02M-3,021.50%-22.07M595.17%12.09M53.76%-2.36M-114.46%-4.2M95.18%-128K-129.35%-707K
-Change in receivables -36.64%697K236.87%245K-76.73%805K284.94%1.28M-294.42%-1.39M238.46%1.1M-108.58%-179K216.77%3.46M198.52%332K15.27%717K
-Change in prepaid assets 9.36%596K-141.86%-758K281.13%1.77M43.26%914K-18.80%-1.5M-42.57%545K239.74%1.81M75.88%-975K149.69%638K-38.06%-1.27M
-Change in payables and accrued expense -38.80%2.6M119.58%516K1,084.64%7.56M306.85%3.63M197.82%2.33M84.17%4.25M44.46%-2.64M-114.17%-768K414.84%891K-78.68%781K
-Change in other current assets 178.95%159K-437.10%-209K91.49%-48K91.13%-18K-325.71%-149K-64.60%57K112.73%62K-78.48%-564K-23.03%-203K---35K
-Change in other current liabilities -96.28%-369K115.79%51K-52.39%-637K-179.03%-346K326.80%220K-80.77%-188K-247.31%-323K-158.02%-418K11.43%-124K-1,112.50%-97K
-Change in other working capital -112.97%-821K36.74%-694K-239.46%-16.77M74.19%-429K-2,572.61%-21.57M433.40%6.33M-91.78%-1.1M-115.87%-4.94M-271.81%-1.66M15.14%-807K
Cash from discontinued investing activities
Operating cash flow -116.44%-32.87M-33.16%-37.2M-2.56%-93.29M14.63%-21.38M-28.66%-28.79M30.58%-15.19M-28.91%-27.94M-179.73%-90.97M-17.09%-25.04M-49.50%-22.38M
Investing cash flow
Cash flow from continuing investing activities 91.61%21.2M10.88%22.96M26.88%-68.18M-2,790.09%-31.47M-721.15%-68.48M179.18%11.06M128.71%20.7M47.14%-93.25M100.67%1.17M-332.07%-8.34M
Net PPE purchase and sale 12.22%-2.24M28.71%-1.45M-79.93%-11.61M-29.60%-2.28M-250.96%-4.75M2.56%-2.55M-180.91%-2.03M-204.29%-6.45M-156.50%-1.76M-45.59%-1.35M
Net intangibles purchase and sale ---125K---1.5M--0--0--0--0--040.00%-600K---300K----
Net investment purchase and sale 73.06%23.57M13.94%25.9M34.37%-56.57M-1,004.77%-29.2M-853.24%-63.72M219.94%13.62M131.85%22.73M50.26%-86.2M101.86%3.23M---6.69M
Cash from discontinued investing activities
Investing cash flow 91.61%21.2M10.88%22.96M26.88%-68.18M-2,790.09%-31.47M-721.15%-68.48M179.18%11.06M128.71%20.7M47.14%-93.25M100.67%1.17M-332.07%-8.34M
Financing cash flow
Cash flow from continuing financing activities -99.25%132K660.35%12.49M7,133.85%154.3M-133.86%-43K20,561.77%135.13M4,753.87%17.57M65.86%1.64M-99.51%2.13M-72.39%127K-99.80%654K
Net common stock issuance -96.14%669K908.82%11.33M--152.72M---113K--134.38M--17.34M--1.12M--0--0--0
Proceeds from stock option exercised by employees -327.54%-537K122.74%1.16M-26.02%1.58M-44.88%70K15.14%753K-34.81%236K-47.58%519K-16.39%2.13M-72.39%127K-31.95%654K
Cash from discontinued financing activities
Financing cash flow -99.25%132K660.35%12.49M7,133.85%154.3M-133.86%-43K20,561.77%135.13M4,753.87%17.57M65.86%1.64M-99.51%2.13M-72.39%127K-99.80%654K
Net cash flow
Beginning cash position -6.33%49.45M-12.29%51.21M-75.72%58.38M26.75%104.1M-40.96%66.24M-64.25%52.79M-75.72%58.38M1,407.34%240.47M-81.13%82.13M-13.41%112.19M
Current changes in cash -185.75%-11.53M68.50%-1.76M96.06%-7.18M-122.75%-52.9M225.96%37.86M137.90%13.45M93.97%-5.59M-181.10%-182.08M87.82%-23.75M-109.83%-30.06M
End cash Position -42.77%37.91M-6.33%49.45M-12.29%51.21M-12.29%51.21M26.75%104.1M-40.96%66.24M-64.25%52.79M-75.72%58.38M-75.72%58.38M-81.13%82.13M
Free cash flow -98.62%-35.23M-33.97%-40.15M-7.02%-104.9M12.71%-23.66M-39.58%-33.54M27.58%-17.74M-33.82%-29.97M-175.03%-98.02M-22.77%-27.1M-42.21%-24.03M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept Gene Editing
Gene Editing
Intraday-0.87%